NOURESS

Avadel Legacy Pharmaceuticals, Llc

Application Filed: 2018-08-24
Trademark Application Details
Trademark Logo NOURESS

Mark For: NOURESS® trademark registration is intended to cover the categories of parenterally-administered pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine deficiencies. [all]

Status

2021-06-24 UTC
DEAD UNKNOWN


Research OneLook Acronym Finder
Serial Number88091317
Registration Number1534387
Mark Literal ElementsNOURESS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-02-11
Basis1(b)
Class StatusABANDONED
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameAustin Padgett
Attorney Docket Number244174.2
Law Office AssignedN50
Employee NameALLEN, BIANCA LEIGH

Timeline

2018-08-24Application Filed
2019-01-15Published
2019-01-15Published for Opposition
2019-03-12Location: INTENT TO USE SECTION
2019-09-03Status: Live/Pending
2019-09-05Transaction Date
2020-02-11Location: INTENT TO USE SECTION
2020-07-02Status: Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Tra

Trademark Parties (Applicants & Owners)

Party: AVADEL LEGACY PHARMACEUTICALS, LLC
Address16640 CHESTERFIELD GROVE ROAD, SUITE 200 CHESTERFIELD, MISSOURI UNITED STATES 63005
Legal Entity TypeLimited Liability Company
Legal Entity StateDELAWARE
Party: Flamel Ireland Limited
Entity Statementlimited company (ltd.)
AddressCorporate Park Block 10-1, Blanchardstown Ballycoolin Dublin IE
Legal Entity Type
Legal Entity State IE

*multiple parties listed, check assignment documents for ownership information

Documents

DrawingJPEG2018-08-24
TEAS RF New ApplicationMULTI2018-08-24
Notation to FileXML2018-12-10
XSearch Search SummaryXML2018-12-10
TRAM Snapshot of App at Pub for OppostnMULTI2018-12-11
Notice of PublicationXML2018-12-26
Notification Of Notice of PublicationXML2018-12-26
OG Publication ConfirmationAPPLICATION/XML2019-01-15
Notice of AllowanceXML2019-03-12
Extension of Time to File SOUXML2019-09-03
ITU Extension ApprovalAPPLICATION/XML2019-09-05
ITU Unit ActionMULTI2019-09-05
Post Publication AmendmentXML2020-01-15
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2020-02-12
Extension of Time to File SOUXML2020-03-03
ITU Extension ApprovalAPPLICATION/XML2020-03-05
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-03-05
Change Address or Representation FormAPPLICATION/XML2020-06-30
Change Address or Representation FormMULTI2020-07-01
Express AbandonmentXML2020-07-01
Notice of AbandonmentXML2020-07-02

Attorney of Record

AUSTIN PADGETT
TROUTMAN SANDERS LLP
600 Peachtree Street NE, Suite 3000
ATLANTA GA 30308

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: parenterally-administered pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine deficiencies

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051parenterally-administered pharmaceuticals for treatment of L-cysteine-deficient newborns and infants; pharmaceuticals for treatment of L-cysteine-deficient newborns and infants; pharmaceuticals for treatment of L-cysteine deficiencies

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION2020-07-02
ABANDONMENT - AFTER PUBLICATION2020-07-02
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-07-01
TEAS EXPRESS ABANDONMENT RECEIVED2020-07-01
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-07-01
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-07-01
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-07-01
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-07-0188888
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-06-30
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-06-30
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-06-30
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-06-30
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-06-3088888
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2020-04-29
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-03-05
TEAS EXTENSION RECEIVED2020-03-03
EXTENSION 2 GRANTED2020-03-0398765
EXTENSION 2 FILED2020-03-0398765
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-02-1171034
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-02-1171034
TEAS POST PUBLICATION AMENDMENT RECEIVED2020-01-15
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-09-05
TEAS EXTENSION RECEIVED2019-09-03
EXTENSION 1 GRANTED2019-09-0398765
EXTENSION 1 FILED2019-09-0398765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-03-12
PUBLISHED FOR OPPOSITION2019-01-15
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-01-15
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2018-12-26
ASSIGNED TO EXAMINER2018-12-1093410
APPROVED FOR PUB - PRINCIPAL REGISTER2018-12-10
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-09-04
NEW APPLICATION ENTERED IN TRAM2018-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed